Study aims to Fine-Tune opioid dosing using pain thresholds
NCT ID NCT07568405
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the opioid remifentanil changes a person's pain threshold before surgery. Researchers will measure pain using a pressure device on the hand at different drug levels. The goal is to better understand how much opioid is needed, which could help personalize anesthesia and reduce postoperative pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
remifentanil (opioid)
What this could lead to
If successful, this could help doctors give more precise opioid doses before surgery, reducing pain and side effects.
What could go wrong
This is a small, early-stage study (40 people) measuring pain thresholds, not testing a new treatment. Results may not apply to all patients or surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HUB Erasme
Brussels, Brussels Capital, 1070, Belgium